SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950103-15-008843
Filing Date
2015-11-13
Accepted
2015-11-13 17:04:51
Documents
4
Group Members
ASTRAZENECA HOLDINGS BVASTRAZENECA INTERMEDIATE HOLDINGS LTDASTRAZENECA PLCASTRAZENECA TREASURY LTDASTRAZENECA UK LTDZANZIBAR ACQUISITION CORP.ZENECA HOLDINGS, INC.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D dp61155_sc13d.htm SC 13D 226975
2 EXHIBIT 1 dp61155_ex9901.htm EX-99.1 487536
3 EXHIBIT 2 dp61155_ex9902.htm EX-99.2 94389
4 EXHIBIT 3 dp61155_ex9903.htm EX-99.3 20403
  Complete submission text file 0000950103-15-008843.txt   830980
Mailing Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019
Business Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019 650-458-4100
ZS Pharma, Inc. (Subject) CIK: 0001459266 (see all company filings)

IRS No.: 263305698 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88212 | Film No.: 151230040
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1800 CONCORD PIKE WILMINGTON DE 19803
Business Address 1800 CONCORD PIKE WILMINGTON DE 19803 800-236-9933
Zeneca, Inc. (Filed by) CIK: 0001657583 (see all company filings)

IRS No.: 510112320 | State of Incorp.: DE
Type: SC 13D